Balentine LLC’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-13,245
| Closed | -$617K | – | 628 |
|
|
2019
Q3 | $617K | Buy |
13,245
+1,224
| +10% | +$57K | 0.04% | 49 |
|
|
2019
Q2 | $628K | Buy |
12,021
+3,033
| +34% | +$158K | 0.04% | 51 |
|
|
2019
Q1 | $620K | Buy |
+8,988
| New | +$620K | 0.04% | 49 |
|
|
2018
Q4 | – | Sell |
-59
| Closed | -$7K | – | 441 |
|
|
2018
Q3 | $7K | Buy |
+59
| New | +$7K | ﹤0.01% | 218 |
|
|
2018
Q1 | – | Sell |
-5,785
| Closed | -$634K | – | 148 |
|
|
2017
Q4 | $634K | Buy |
5,785
+481
| +9% | +$52.7K | 0.05% | 49 |
|
|
2017
Q3 | $524K | Buy |
5,304
+38
| +0.7% | +$3.75K | 0.04% | 51 |
|
|
2017
Q2 | $533K | Buy |
5,266
+347
| +7% | +$35.1K | 0.05% | 47 |
|
|
2017
Q1 | $568K | Buy |
4,919
+5
| +0.1% | +$577 | 0.06% | 38 |
|
|
2016
Q4 | $590K | Buy |
4,914
+370
| +8% | +$44.4K | 0.06% | 31 |
|
|
2016
Q3 | $510K | Buy |
4,544
+3,651
| +409% | +$410K | 0.07% | 36 |
|
|
2016
Q2 | $111K | Buy |
893
+274
| +44% | +$34.1K | 0.02% | 104 |
|
|
2016
Q1 | $70K | Hold |
619
| – | – | 0.02% | 97 |
|
|
2015
Q4 | $67K | Sell |
619
-165
| -21% | -$17.9K | 0.01% | 139 |
|
|
2015
Q3 | $78K | Hold |
784
| – | – | 0.01% | 119 |
|
|
2015
Q2 | $89K | Sell |
784
-465
| -37% | -$52.8K | 0.01% | 101 |
|
|
2015
Q1 | $131K | Buy |
+1,249
| New | +$131K | 0.02% | 76 |
|